Charpidou, Andriani et al
"Immune-related adverse events as a predictor marker of response to programmed cell death 1/programmed death-ligand 1 axis inhibitors in patients with non-small cell lung cancer." European Respiratory Journal
58.suppl 65
(2021):
PA2305.
Web. 19 April. 2024.